Locally Advanced Adrenal Cortical Carcinoma
Oncology·MeSH: Adrenocortical Carcinoma
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Cabozantinib | Royalty Pharma plc (RPRX) |
Phase 2(1)
| Drug | Company |
|---|---|
| Cemiplimab | Royalty Pharma plc (RPRX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Locally Advanced Adrenal Cortical Carcinoma?
BioSniper tracks 2 drugs in development for Locally Advanced Adrenal Cortical Carcinoma across 1 company.
How many clinical trials target Locally Advanced Adrenal Cortical Carcinoma?
There are 1 clinical trial targeting Locally Advanced Adrenal Cortical Carcinoma tracked by BioSniper.
Deep-dive into Locally Advanced Adrenal Cortical Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis